Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants

Trial Profile

Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Nov 2016

At a glance

  • Drugs Apixaban (Primary) ; Clarithromycin
  • Indications Venous thromboembolism
  • Focus Pharmacokinetics
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 18 Nov 2016 Status changed from recruiting to completed.
    • 06 Oct 2016 Status changed from not yet recruiting to recruiting.
    • 30 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top